Rationalization of risk factors for venous thromboembolism in medical in-patients: A prospective study;Rationalisation des facteurs de risque de la maladie thrombo-embolique veineuse en milieu medical polyvalent hospitalier: Une etude prospective

Journal des Maladies Vasculaires

Volumn 25, Issue 4, 2000, Pages 241-249

  Pottier, P ^a   Planchon, B ^a   Truchaud, F ^a   Pistorius, M A ^a   Furic, I ^a   Grolleau, J Y ^a  

^a HÔTEL DIEU   (France)

Author keywords

Deep venous thrombosis; Low molecular weight heparin; Risk factors

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN;

ADULT; ARTICLE; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; ECONOMIC ASPECT; FEMALE; HOSPITAL PATIENT; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SCORING SYSTEM; SUDDEN DEATH; THROMBOEMBOLISM; VEIN THROMBOSIS;

ADULT; AGED; ANTICOAGULANTS; FRANCE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INCIDENCE; INPATIENTS; MIDDLE AGED; NADROPARIN; PROSPECTIVE STUDIES; RISK FACTORS; THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 0033757155     PISSN: 03980499     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Prevention of venous thrombosis and pulmonary embolism
2. Risk of and prophylaxis for venous thromboembolism in hospital patients
3. Prophylaxie des thromboses veineuses postoperatoires: Recommandations de l'Assistance Publique - Hopitaux de Paris
4. Prevention of venous thromboembolism
5. Incidence of deep vein thrombosis and the effect of pneumatic compression of the calf in elderly hemiplegics
6. Acute spinal cord injuries and the incidence of clinically occurring thromboembolic disease
7. Risk assessment of pulmonary embolism by multivariate analysis
8. Post-operative deep venous thrombosis and low-molecular weight heparin type and dosage
9. Prevention of thromboembolic accidents in elderly subjects with Fraxiparine(*). Fraxiparine
10. Randomized controlled study of heparin and low molecular weight heparin for prevention of deep-vein thrombosis in medical patients
11. Subcutaneous low-molecular-weight heparin versus standard heparin and the prevention of thromboembolism in medical inpatients
12. The venous thrombotic risk in non-surgical patients: Epidemiological data and efficacy/safety profile of a low-molecular-weight heparin (enoxaparin)
13. A Multicenter randomized double-blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness
14. Prevention of deep vein thrombosis in elderly medical in-patients by a low molecular weight heparin: A randomized double-blind trial
15. Tolerance to calcium nadroparin for the prevention of thromboembolism in the elderly
16. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients
17. Deep venous thrombosis in spinal cord injury. Overview of the problem
18. Double-blind randomized trial of ORG 10172 low-molecular-weight heparinoid in prevention of deepvein thrombosis in thrombotic stroke
19. Smoking and risk factors in deep vein thrombosis
20. Prevention of deep vein thrombosis in medical patients by low-dose heparin
21. Reduction of mortality in general medical in-patients by low-dose heparin prophylaxis
22. Incidence of deep vein thrombosis in bedridden non-surgical patients
23. High risk of the critically ill for venous thromboembolism
24. Randomised, controlled trial of low-dose heparin for prevention of fatal pulmonary embolism in patients with infectious diseases
25. Venous thromboembolic disease of the elderly Detection and treatment